{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:56:28Z","timestamp":1791860188751,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"Saint Baldricks Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P30CA124435-16"],"award-info":[{"award-number":["2P30CA124435-16"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35CA283888"],"award-info":[{"award-number":["R35CA283888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R0CA263500-01"],"award-info":[{"award-number":["R0CA263500-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P01CA217959-06A1"],"award-info":[{"award-number":["2P01CA217959-06A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023479","name":"CRIS Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Ramon Areces Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006352","name":"Virginia and DK Ludwig Fund for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"The Mark Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cell.2026.04.037","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:27:53Z","timestamp":1778858873000},"page":"3883-3902.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis"],"prefix":"10.1016","volume":"189","author":[{"given":"Jeremy R.","family":"Bjelajac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Ca\u00f1ellas-Socias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Malipatlolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiara","family":"Martinez Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Manjarrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Yamada-Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louai","family":"Labanieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sotillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Mackall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.04.037_bib1","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib4","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1200\/JCO.19.02104","article-title":"Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium","volume":"38","author":"Nastoupil","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.04.037_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.04.037_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.20.03585","article-title":"Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report","volume":"40","author":"Schultz","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.04.037_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.04.037_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(24)00746-3","article-title":"CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study","volume":"404","author":"Frank","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.04.037_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.04.037_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4\u20131BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2021.06.012","article-title":"The role of exhaustion in CAR T cell therapy","volume":"39","author":"Delgoffe","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib15","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","article-title":"An NK-like CAR T cell transition in CAR T cell dysfunction","volume":"184","author":"Good","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib16","first-page":"3153","article-title":"Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction","volume":"141","author":"Selli","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.04.037_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4049\/jimmunol.1700236","article-title":"Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains","volume":"200","author":"Harris","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2026.04.037_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-19-0945","article-title":"Tuning the Antigen Density Requirement for CAR T-cell Activity","volume":"10","author":"Majzner","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.04.037_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.medj.2022.05.001","article-title":"Understanding CAR T cell-tumor interactions: Paving the way for successful clinical outcomes","volume":"3","author":"Korell","year":"2022","journal-title":"Med."},{"key":"10.1016\/j.cell.2026.04.037_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.04.037_bib21","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221988","article-title":"Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy","volume":"221","author":"Lin","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2326-6066.CIR-14-0186","article-title":"Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells","volume":"3","author":"Frigault","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.04.037_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-0716-0146-4_17","article-title":"Analysis of CAR-Mediated Tonic Signaling","volume":"2086","author":"Calderon","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-021-01326-5","article-title":"Antigen-independent activation enhances the efficacy of 4\u20131BB-costimulated CD22 CAR T cells","volume":"27","author":"Singh","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib25","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00262-022-03195-4","article-title":"Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor","volume":"71","author":"Wang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cell.2026.04.037_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2326-6066.CIR-22-0504","article-title":"Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR","volume":"11","author":"Chen","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.04.037_bib27","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/2159-8290.CD-23-1393","article-title":"Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors","volume":"14","author":"Chang","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.04.037_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s42255-024-01034-7","article-title":"Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation","volume":"6","author":"Lakhani","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cell.2026.04.037_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2026.04.037_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.185.4.641","article-title":"Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells","volume":"185","author":"Cai","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib31","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1084\/jem.185.10.1859","article-title":"Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation","volume":"185","author":"Valitutti","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1074-7613(00)00066-2","article-title":"On the dynamics of TCR:CD3 complex cell surface expression and downmodulation","volume":"13","author":"Liu","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.04.037_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tibs.2005.05.006","article-title":"Shedding light on ADAM metalloproteinases","volume":"30","author":"Huovila","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cell.2026.04.037_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899456","article-title":"Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments","volume":"37","author":"Lichtenthaler","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.04.037_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01744-z","article-title":"Role of ADAM and ADAMTS proteases in pathological tissue remodeling","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cell.2026.04.037_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1084\/jem.20040435","article-title":"Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases","volume":"200","author":"Xanthoulea","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib37","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1091\/mbc.e08-11-1135","article-title":"ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha","volume":"20","author":"Le Gall","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib38","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1242\/dev.076398","article-title":"Ectodomain shedding and ADAMs in development","volume":"139","author":"Weber","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.cell.2026.04.037_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102259","article-title":"Exploring the landscape of ectodomain shedding by quantitative protein terminomics","volume":"24","author":"Tsumagari","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.cell.2026.04.037_bib40","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1242\/jcs.069997","article-title":"ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site","volume":"123","author":"Le Gall","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cell.2026.04.037_bib41","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2174\/138161209788682442","article-title":"ADAM10 as a therapeutic target for cancer and inflammation","volume":"15","author":"Crawford","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cell.2026.04.037_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26040944","article-title":"Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution","volume":"26","author":"Calligaris","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cell.2026.04.037_bib43","first-page":"243","article-title":"Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A","volume":"9","author":"O'Neil-Andersen","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.cell.2026.04.037_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1083\/jcb.132.4.565","article-title":"The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane","volume":"132","author":"Rohrer","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167215","article-title":"Time-Dependent Regulation of IL-2R \u03b1-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes","volume":"11","author":"Shatrova","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.cell.2026.04.037_bib46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/cib.3.6.13495","article-title":"Multifaceted regulation of T cells by CD44","volume":"3","author":"Baaten","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib47","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/jid.2009.13","article-title":"Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding","volume":"129","author":"Stamenkovic","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.cell.2026.04.037_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-3083.2009.02268.x","article-title":"CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2","volume":"70","author":"Pedersen","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cell.2026.04.037_bib49","article-title":"The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes","volume":"6","author":"Yang","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.cell.2026.04.037_bib50","article-title":"Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.04.037_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52666-y","article-title":"GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency","volume":"15","author":"Guerrero","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.04.037_bib52","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.jproteome.3c00001","article-title":"SheddomeDB 2023: A Revision of an Ectodomain Shedding Database Based on a Comprehensive Literature Review and Online Resources","volume":"22","author":"Huang","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cell.2026.04.037_bib53","doi-asserted-by":"crossref","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database","volume":"46","author":"Rawlings","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2026.04.037_bib54","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.04.037_bib55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200307137","article-title":"Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands","volume":"164","author":"Sahin","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1083\/jcb.125.2.461","article-title":"Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin","volume":"125","author":"Kahn","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11523","article-title":"Phosphatidylserine exposure is required for ADAM17 sheddase function","volume":"7","author":"Sommer","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.04.037_bib58","article-title":"Control of ADAM17 activity by regulation of its cellular localisation","volume":"6","author":"Lorenzen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2026.04.037_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.cell.2026.04.037_bib60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00018-020-03507-w","article-title":"The metalloproteinase ADAM10 requires its activity to sustain surface expression","volume":"78","author":"Seifert","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cell.2026.04.037_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","article-title":"c-Jun overexpression in CAR T cells induces exhaustion resistance","volume":"576","author":"Lynn","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.04.037_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.04.037_bib63","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/bloodadvances.2018028720","article-title":"Pharmacologic control of CAR-T cell function using dasatinib","volume":"3","author":"Weber","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.cell.2026.04.037_bib64","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1084\/jem.20150194","article-title":"Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection","volume":"212","author":"Omilusik","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/JLB.5A0621-314R","article-title":"Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2","volume":"111","author":"Wu","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib66","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1200\/JCO.21.00917","article-title":"Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia","volume":"39","author":"Roddie","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.04.037_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01886-9","article-title":"Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cell.2026.04.037_bib68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","article-title":"Calcium signalling in T cells","volume":"19","author":"Trebak","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.04.037_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","article-title":"The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells","volume":"42","author":"Martinez","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.04.037_bib70","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1535-7163.MCT-17-1097","article-title":"Strategies to Address Chimeric Antigen Receptor Tonic Signaling","volume":"17","author":"Ajina","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cell.2026.04.037_bib71","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","article-title":"Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness","volume":"33","author":"Chen","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2026.04.037_bib72","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4161\/cbt.8.22.9765","article-title":"Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies","volume":"8","author":"Donaldson","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cell.2026.04.037_bib73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymthe.2016.10.011","article-title":"Masked Chimeric Antigen Receptor for Tumor-Specific Activation","volume":"25","author":"Han","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cell.2026.04.037_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41589-019-0443-y","article-title":"A tunable orthogonal coiled-coil interaction toolbox for engineering mammalian cells","volume":"16","author":"Lebar","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.04.037_bib75","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.04.037_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn5647","article-title":"Enhanced T cell effector activity by targeting the Mediator kinase module","volume":"378","author":"Freitas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.04.037_bib77","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ccell.2022.06.001","article-title":"Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence","volume":"40","author":"Belk","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib78","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.04.037_bib79","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000676","article-title":"Inhibition of TGF-beta-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer","volume":"8","author":"St\u00fcber","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cell.2026.04.037_bib81","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGFbeta-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib82","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.04.037_bib83","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13Ralpha2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib84","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1038\/s41591-025-03745-0","article-title":"Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Ralpha2 in recurrent glioblastoma: a phase 1 trial","volume":"31","author":"Bagley","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib85","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41586-024-08261-8","article-title":"Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers","volume":"637","author":"Steffin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.04.037_bib86","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(25)00860-8","article-title":"Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial","volume":"405","author":"Qi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.04.037_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03442-3","article-title":"Exhaustion of CAR T cells: potential causes and solutions","volume":"20","author":"Kouro","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cell.2026.04.037_bib88","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/bloodadvances.2023012416","article-title":"CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy","volume":"8","author":"Ledergor","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.cell.2026.04.037_bib89","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.04.037_bib90","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","article-title":"Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors","volume":"167","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib91","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.cell.2022.03.023","article-title":"Modular design of synthetic receptors for programmed gene regulation in cell therapies","volume":"185","author":"Zhu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib92","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cell.2018.03.038","article-title":"Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses","volume":"173","author":"Cho","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib93","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cels.2022.09.006","article-title":"Recent progress of gene circuit designs in immune cell therapies","volume":"13","author":"Lee","year":"2022","journal-title":"Cell Syst."},{"key":"10.1016\/j.cell.2026.04.037_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021337","article-title":"Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and gamma-secretase","volume":"6","author":"Hogl","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.cell.2026.04.037_bib95","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.cell.2017.11.014","article-title":"Structural Basis for Regulated Proteolysis by the alpha-Secretase ADAM10","volume":"171","author":"Seegar","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib96","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.04.037_bib97","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cell.2026.04.037_bib98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nmeth.2413","article-title":"A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum","volume":"10","author":"Shaner","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2026.04.037_bib99","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cell.2022.03.041","article-title":"Enhanced safety and efficacy of protease-regulated CAR-T cell receptors","volume":"185","author":"Labanieh","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.04.037_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057838","article-title":"Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials","volume":"8","author":"Jena","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.cell.2026.04.037_bib101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002371-199801000-00010","article-title":"Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2","volume":"21","author":"Sen","year":"1998","journal-title":"J. Immunother."},{"key":"10.1016\/j.cell.2026.04.037_bib102","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","article-title":"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.04.037_bib103","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.ymthe.2017.06.008","article-title":"Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase","volume":"25","author":"Walker","year":"2017","journal-title":"Mol. Ther."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426005040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426005040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:35:41Z","timestamp":1785893741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867426005040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":103,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0092867426005040"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.04.037","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}